No mix and match of Covid-19 vaccine doses anytime soon: VK Paul, member-health, Niti Aayog

Nevertheless, such a mix of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin was not being thought of, Paul mentioned at a press briefing.

A mixture and match of Covid-19 vaccine doses is unlikely to occur within the nation anytime quickly, VK Paul, member-health, Niti Aayog, indicated on Saturday. Preliminary outcomes from a trial in UK, the place a mix of the Oxford-AstraZeneca and Pfizer-BioNTech Covid-19 vaccines got, generated excessive immune response in opposition to the SARS-COV-2 virus.

Nevertheless, such a mix of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin was not being thought of, Paul mentioned at a press briefing. Mixing of vaccine doses was theoretically attainable, however was not at a stage the place it may very well be really useful, he identified.

“This was an evolving science and was not definitive,” Paul mentioned, including there was no sturdy scientific proof to assist, and name could be taken solely after seeing the way it evolves all over the world and conducting extra research within the nation.